Ratings by Truist Securities (Robyn Karnauskas)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 1/8/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/8/2025 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2024 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Amgen | AMGN | Downgrade | Hold (Buy) |
328.35 (369.53) |
12.54% | Details | |
| 10/10/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 10/3/2024 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 9/25/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2024 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Tourmaline Bio | TRML | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
5.74 (2.38) |
-58.54% | Details | |
| 2/22/2024 | Gilead Sciences | GILD | Downgrade | Hold (Buy) |
73.20 (143.93) |
96.63% | Details | |
| 2/6/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
18.60 (4.14) |
-77.74% | Details | |
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2023 | RayzeBio | RYZB | Downgrade | Hold (Buy) |
61.40 (62.49) |
1.78% | Details | |
| 12/14/2023 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2023 | Tourmaline Bio | TRML | New Coverage | Buy (N/A) |
16.11 (30.18) |
87.34% | Details | |
| 11/15/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Amgen | AMGN | Upgrade | Buy (Hold) |
260.84 (328.35) |
25.88% | Details | |
| 10/27/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2023 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2023 | RayzeBio | RYZB | New Coverage | Buy (N/A) |
21.03 (62.49) |
197.15% | Details | |
| 10/5/2023 | PTC Therapeutics | PTCT | Downgrade | Hold (Buy) |
21.20 (51.87) |
144.67% | Details | |
| 10/4/2023 | BioXcel Therapeutics | BTAI | Downgrade | Hold (Buy) |
2.34 (1.48) |
-36.75% | Details | |
| 9/26/2023 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2023 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2023 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2023 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2023 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Fate Therapeutics | FATE | Downgrade | Hold (Buy) |
11.12 (1.33) |
-88.04% | Details | |
| 1/4/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2022 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.24 (1.89) |
-41.67% | Details | |
| 12/6/2022 | MEI Pharma | MEIP | Downgrade | Hold (Buy) |
0.41 (3.07) |
648.78% | Details | |
| 11/28/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2022 | Instil Bio Inc | TIL | Downgrade | Hold (Buy) |
5.25 (8.87) |
68.95% | Details | |
| 10/28/2022 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
70.82 (73.20) |
3.36% | Details | |
| 10/10/2022 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2022 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 9/8/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2022 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 8/8/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2022 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2022 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2022 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 7/18/2022 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
3.38 (5.74) |
69.82% | Details | |
| 7/8/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2022 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 6/28/2022 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2022 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2022 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2022 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2022 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 5/10/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2022 | PTC Therapeutics | PTCT | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2022 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2022 | Abbvie | ABBV | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/19/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (Buy) |
|
Details | ||
| 4/19/2022 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2022 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 4/6/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (Buy) |
|
Details | ||
| 4/5/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2022 | Infinity Pharmaceutical | INFI | Maintain | Buy (Buy) |
|
Details | ||
| 3/29/2022 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 3/25/2022 | MEI Pharma | MEIP | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2022 | Gilead Sciences | GILD | Maintain | Hold (Hold) |
|
Details | ||
| 3/3/2022 | NuCana | NCNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Fate Therapeutics | FATE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2022 | Kodiak Sciences Inc. | KOD | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2022 | Gilead Sciences | GILD | Maintain | Hold (Hold) |
|
Details | ||
| 2/16/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Abbvie | ABBV | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Kodiak Sciences Inc. | KOD | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Roivant Sciences | ROIV | Maintain | Buy (Buy) |
|
Details | ||
| 2/14/2022 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Amgen | AMGN | Maintain | Hold (Hold) |
|
Details | ||
| 2/9/2022 | Pfizer | PFE | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2022 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 2/2/2022 | Gilead Sciences | GILD | Maintain | Hold (Hold) |
|
Details | ||
| 1/31/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2022 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2022 | Arcus Biosciences | RCUS | Maintain | Buy (Buy) |
|
Details | ||
| 1/7/2022 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 1/7/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2022 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 12/2/2021 | Vertex | VRTX | Maintain | (N/A) |
|
Details | ||
| 12/1/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Hold (N/A) |
|
Details | ||
| 11/17/2021 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Deciphera | DCPH | Downgrade | Hold (Buy) |
36.00 (25.59) |
-28.92% | Details | |
| 10/26/2021 | Roivant Sciences | ROIV | New Coverage | Buy (N/A) |
7.04 (28.78) |
308.81% | Details | |
| 10/21/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Hold (Buy) |
37.30 (38.22) |
2.47% | Details | |
| 7/27/2021 | Infinity Pharmaceutical | INFI | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Pfizer | PFE | New Coverage | Buy (N/A) |
41.68 (27.05) |
-35.1% | Details | |
| 7/26/2021 | Merck | MRK | New Coverage | Buy (N/A) |
77.54 (115.79) |
49.33% | Details | |
| 7/26/2021 | Eli Lilly | LLY | New Coverage | Buy (N/A) |
244.15 (990.33) |
305.62% | Details | |
| 7/26/2021 | Bristol-Myers Squibb Co. | BMY | New Coverage | Buy (N/A) |
68.34 (60.29) |
-11.78% | Details | |
| 7/26/2021 | Abbvie | ABBV | New Coverage | Buy (N/A) |
118.19 (230.11) |
94.69% | Details | |
| 7/12/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2021 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2021 | Instil Bio Inc | TIL | New Coverage | Buy (N/A) |
21.94 (8.87) |
-59.57% | Details | |
| 3/18/2021 | Infinity Pharmaceutical | INFI | New Coverage | Buy (N/A) |
3.20 (0.04) |
-98.75% | Details | |
| 3/15/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2021 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 3/2/2021 | Athenex | ATNX | Downgrade | Hold (Buy) |
12.10 (0.20) |
-98.35% | Details | |
| 3/1/2021 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2021 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2021 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 2/4/2021 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/2/2021 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 12/16/2020 | Alexion Pharmaceuticals | ALXN | Downgrade | Hold (Buy) |
156.31 (182.01) |
16.44% | Details | |
| 11/23/2020 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/10/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2020 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2020 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2020 | NuCana | NCNA | New Coverage | Buy (N/A) |
5.06 (2.16) |
-57.31% | Details | |
| 10/12/2020 | Amgen | AM2GN | Upgrade | Buy (Hold) |
236.70 () |
-100% | Details | |
| 10/9/2020 | Amgen | AMGN | Downgrade | Hold (Buy) |
257.67 (369.53) |
43.41% | Details | |
| 10/8/2020 | Applied Therapeutics | APLT | New Coverage | Buy (N/A) |
21.33 (0.10) |
-99.53% | Details | |
| 8/26/2020 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2020 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details |
